What is the Southeast Clinical Oncology Research Consortium?
The Southeast Clinical Oncology Research Consortium (also called SCOR) is a group of community physicians composed of medical oncologists, surgeons, radiation oncologists, and gynecologic oncologists located in the southeastern United States. SCOR is funded by the National Cancer Institute (called NCI) through the Community Oncology Research Program (called NCORP). SCOR physicians are located in communities covering a six-state area (Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia). These physicians are committed to bring cancer clinical trials to their local community. SCOR helps facilitate the connection between SCOR institutions (hospitals, medical centers, and private practices), patients, and the clinical trials patients seek, thereby allowing SCOR members to provide “state-of-the-art” and innovative cancer treatment to those patients in need. The role SCOR plays in this process is essential. SCOR adheres to the guidelines and regulations set by the NCI. All clinical trials are reviewed and approved by the NCI Central Institutional Review Board (CIRB) or in rare instances, may require approval by the local IRB.
Who Can Benefit from the SCOR Website?
The goal of the SCOR website is to help provide patients with the information necessary to connect with doctors who participate in cancer clinical trials by using the information located on the SCOR website. Clinical trials are available for consenting adults seeking alternative treatments to help improve the quality of their cancer treatment, reduce morbidity, and ultimately prevent mortality through early detection.